1887
Volume 2025, Issue 4
  • ISSN: 0253-8253
  • EISSN: 2227-0426

Abstract

Dexmedetomidine is a highly selective αadrenergic agonist with sedo-analgesic properties. It has been approved by the United States Food and Drug Administration (FDA) for sedation of critically ill patients, facilitation of awake procedures, and management of patient agitation. However, its use has been occasionally associated with adverse effects like bradycardia, hypotension, and asystole. The risk of these effects, particularly cardiac arrest, is increased in the elderly, patients with multiple comorbidities, and administration of higher doses of the drug (especially loading doses). However, perioperative pericardiac arrest with only low-dose dexmedetomidine infusion, in a young healthy male, has not been previously reported.

We report a 33-year-old male, ASA 1 E, who underwent open reduction and internal fixation of a left ankle fracture under spinal anesthesia. He was sedated intraoperatively with intravenous dexmedetomidine, infused at 0.2 μg/kg/h, without a loading dose. Approximately 90 minutes into the procedure, he had severe bradycardia and hypotension, leading to a peri-arrest situation. He was successfully revived with intravenous atropine and ephedrine and completed the surgery uneventfully.

We opine that the use of dexmedetomidine as a sedative agent in patients under spinal anesthesia requires heightened caution due to the risk of major adverse cardiac events. Our case exemplifies that this risk persists even in healthy young patients, at low drug infusion rates, and even after avoiding a loading dose.

© 2025 Alhammad, Khan, Karmakar, Kassas, Hammad, Ahmed, et al., licensee HBKU Press.
Loading

Article metrics loading...

/content/journals/10.5339/qmj.2025.117
2025-12-14
2025-12-14

Metrics

Loading full text...

Full text loading...

/deliver/fulltext/qmj/2025/4/qmj.2025.117.html?itemId=/content/journals/10.5339/qmj.2025.117&mimeType=html&fmt=ahah

References

  1. Mangano DT. Peri-operative cardiovascular morbidity: new developments. Best Pract Res Clin Anaesthesiol. 1999 Oct; 13:: 335–48. https://doi.org/10.1053/bean.1999.0032
     [Google Scholar]
  2. Armstrong RA, Soar J, Kane AD, Kursumovic E, Nolan JP, Oglesby FC, et al.. Peri-operative cardiac arrest: epidemiology and clinical features of patients analysed in the 7th National Audit Project of the Royal College of Anaesthetists. Anaesthesia. 2024 Jan; 79:(1):18–30. https://doi.org/10.1111/anae.16156
     [Google Scholar]
  3. Armstrong RA, Cook TM, Kane AD, Kursumovic E, Nolan JP, Oglesby FC, et al.. Peri-operative cardiac arrest: management and outcomes of patients analysed in the 7th National Audit Project of the Royal College of Anaesthetists. Anaesthesia. 2024 Jan; 79:(1):31–42. https://doi.org/10.1111/anae.16157
     [Google Scholar]
  4. Kouz K, Hoppe P, Reese P, Burfeindt C, Flick M, Briesenick L, et al.. Relationship between intraoperative and preoperative ambulatory nighttime heart rates: a secondary analysis of a prospective observational study. Anesth Analg. 2021 Aug; 133:(2):406–12. https://doi.org/10.1213/ANE.0000000000005625
     [Google Scholar]
  5. Bohringer C, Liu H. Is it time for an expanded role of dexmedetomidine in contemporary anesthesia practice? - a clinician’s perspective. Transl Perioper Pain Med. 2018; 5:(3):55–62.
    [Google Scholar]
  6. Weerink MAS, Struys M, Hannivoort LN, Barends CRM, Absalom AR, Colin P. Clinical pharmacokinetics and pharmacodynamics of dexmedetomidine. Clin Pharmacokinet. 2017 Aug; 56:(8):893–913. https://doi.org/10.1007/s40262-017-0507-7
     [Google Scholar]
  7. Grape S, Kirkham KR, Frauenknecht J, Albrecht E. Intra-operative analgesia with remifentanil vs. dexmedetomidine: a systematic review and meta-analysis with trial sequential analysis. Anaesthesia. 2019 Jun; 74:(6):793–800. https://doi.org/10.1111/anae.14657
     [Google Scholar]
  8. Hui C, Cardinale M, Yegneswaran B. Significant bradycardia in critically ill patients receiving dexmedetomidine and fentanyl. Case Rep Crit Care. 2017; 2017:: 4504207. https://doi.org/10.1155/2017/4504207
     [Google Scholar]
  9. Sangkum L, Termpornlert S, Tunprasit C, Rathanasutthajohn C, Komonhirun R, Dusitkasem S. Effect of low-dose dexmedetomidine to prolong spinal anesthesia in elderly patients: a prospective randomized controlled study. BMC Anesthesiol. 2024 Nov; 24:: 427. https://doi.org/10.1186/s12871-024-02815-z
     [Google Scholar]
  10. Vijay Y, Hussain A, Shekhawat DS. Enhancing spinal anesthesia with dexmedetomidine: a prospective study on prolonging analgesia and reducing opioid requirements in infra umbilical surgeries. Int J Curr Pharm Res. 2025 Jan-Feb; 17:(1):65–8. https://doi.org/10.22159/ijcpr.2025v17i1.6028
     [Google Scholar]
  11. Bloor BC, Ward DS, Belleville JP, Maze M. Effects of intravenous dexmedetomidine in humans. II. Hemodynamic changes. Anesthesiology. 1992 Dec; 77:(6):1134–42. https://doi.org/10.1097/00000542-199212000-00014
     [Google Scholar]
  12. Arain SR, Ebert TJ. The efficacy, side effects, and recovery characteristics of dexmedetomidine versus propofol when used for intraoperative sedation. Anesth Analg. 2002 Aug; 95:(2):461–6, table of contents. https://doi.org/10.1097/00000539-200208000-00042
     [Google Scholar]
  13. Atkinson TM, Giraud GD, Togioka BM, Jones DB, Cigarroa JE. Cardiovascular and ventilatory consequences of laparoscopic surgery. Circulation. 2017 Feb; 135:(7):700–10. https://doi.org/10.1161/CIRCULATIONAHA.116.023262
     [Google Scholar]
  14. Dhoste K, Lacoste L, Karayan J, Lehuede MS, Thomas D, Fusciardi J. Haemodynamic and ventilatory changes during laparoscopic cholecystectomy in elderly ASA III patients. Can J Anaesth. 1996 Aug; 43:(8):783–8. https://doi.org/10.1007/BF03013029
     [Google Scholar]
  15. U.S. Food and Drug Administration . Prescribing information for Dexmedetomidine, 2021. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/206628s017lbl.pdf. Accessed January 18, 2025.
    [Google Scholar]
  16. Ahn EJ, Park JH, Kim HJ, Kim KW, Choi HR, Bang SR. Anticholinergic premedication to prevent bradycardia in combined spinal anesthesia and dexmedetomidine sedation: a randomized, double-blind, placebo-controlled study. J Clin Anesth. 2016 Dec; 35:: 13–9. https://doi.org/10.1016/j.jclinane.2016.07.012
     [Google Scholar]
  17. Colin PJ, Hannivoort LN, Eleveld DJ, Reyntjens KMEM, Absalom AR, Vereecke HEM, et al.. Dexmedetomidine pharmacodynamics in healthy volunteers: 2. Haemodynamic profile. Br J Anaesth. 2017 Aug; 119:(2):211–20. https://doi.org/10.1093/bja/aex086
     [Google Scholar]
  18. Park SW, Choi JH, Kim HT, Cho YH. Replacement of dexmedetomidine loading with midazolam for sedation in elderly patients with spinal anesthesia. Medicine (Baltimore). 2018 Sep; 97:(39):e12565. https://doi.org/10.1097/MD.0000000000012565
     [Google Scholar]
  19. Elcıcek K, Tekın M, Katı I. The effects of intravenous dexmedetomidine on spinal hyperbaric ropivacaine anesthesia. J Anesth. 2010 Aug; 24:(4):544–8. https://doi.org/10.1007/s00540-010-0939-9
     [Google Scholar]
  20. Schoemaker RC, van Gerven JM, Cohen AF. Estimating potency for the Emax-model without attaining maximal effects. J Pharmacokinet Biopharm. 1998 Oct; 26:(5):581–93. https://doi.org/10.1023/a:1023277201179
     [Google Scholar]
  21. Kusumoto FM, Schoenfeld MH, Barrett C, Edgerton JR, Ellenbogen KA, Gold MR, et al.. 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, and the Heart Rhythm Society. J Am Coll Cardiol. 2019 Aug; 74:(7):932–87. https://doi.org/10.1016/j.jacc.2018.10.043
     [Google Scholar]
  22. Saugel B, Vincent JL, Wagner JY. Personalized hemodynamic management. Curr Opin Crit Care. 2017 Aug; 23:(4):334–41. https://doi.org/10.1097/MCC.0000000000000422
     [Google Scholar]
  23. Fujii E, Tanaka-Mizuno S, Fujino K, Fujii M, Furuno M, Sugimoto Y, et al.. Dexmedetomidine attenuates the positive chronotropic effects of intravenous atropine in patients with bradycardia during spinal anaesthesia: a retrospective study. JA Clin Rep. 2018 Sep; 4:(1):70. https://doi.org/10.1186/s40981-018-0207-9
     [Google Scholar]
  24. Nishikawa T, Dohi S. Oral clonidine blunts the heart rate response to intravenous atropine in humans. Anesthesiology. 1991 Aug; 75:(2):217–22. https://doi.org/10.1097/00000542-199108000-00008
     [Google Scholar]
  25. Ko KH, Jun IJ, Lee S, Lim Y, Yoo B, Kim KM. Effective dose of dexmedetomidine to induce adequate sedation in elderly patients under spinal anesthesia. Korean J Anesthesiol. 2015 Dec; 68:(6):575–80. https://doi.org/10.4097/kjae.2015.68.6.575
     [Google Scholar]
  26. Ebert TJ, Hall JE, Barney JA, Uhrich TD, Colinco MD. The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology. 2000 Aug; 93:(2):382–94. https://doi.org/10.1097/00000542-200008000-00016
     [Google Scholar]
  27. Yang H, Fu Y, Deng F, Shao Y, Lu YG, Song JC. Median effective dose of dexmedetomidine inducing Bradycardia in elderly patients determined by up-and-down sequential allocation method. Int J Med Sci. 2022 Jun; 19:(6):1065–71. https://doi.org/10.7150/ijms.71380
     [Google Scholar]
  28. Gerlach AT, Murphy CV. Dexmedetomidine-associated bradycardia progressing to pulseless electrical activity: case report and review of the literature. Pharmacotherapy. 2009 Dec; 29:(12):1492. https://doi.org/10.1592/phco.29.12.1492
     [Google Scholar]
  29. Shah AN, Koneru J, Nicoara A, Goldfeder LB, Thomas K, Ehlert FA. Dexmedetomidine related cardiac arrest in a patient with permanent pacemaker; a cautionary tale. Pacing Clin Electrophysiol. 2007 Sep; 30:(9):1158–60. https://doi.org/10.1111/j.1540-8159.2007.00829.x
     [Google Scholar]
  30. Nagasaka Y, Machino A, Fujikake K, Kawamoto E, Wakamatsu M. [Cardiac arrest induced by dexmedetomidine]. Masui. 2009 Aug; 58:(8):987–9.
    [Google Scholar]
  31. Takata K, Adachi YU, Suzuki K, Obata Y, Sato S, Nishiwaki K. Dexmedetomidine-induced atrioventricular block followed by cardiac arrest during atrial pacing: a case report and review of the literature. J Anesth. 2014 Feb; 28:(1):116–20. https://doi.org/10.1007/s00540-013-1676-7
     [Google Scholar]
  32. Kim HJ, Ahn E. Risk factors for dexmedetomidine-associated bradycardia during spinal anesthesia: a retrospective study. Medicine (Baltimore). 2022 Oct; 101:(43):e31306. https://doi.org/10.1097/MD.0000000000031306
     [Google Scholar]
  33. Lao HC, Tsai PS, Su JY, Kwok TG, Huang CJ. Dexmedetomidine attenuates tourniquet-induced hyperdynamic response in patients undergoing lower limb surgeries: a randomized controlled study. J Surg Res. 2013 Jan; 179:(1):e99–e106. https://doi.org/10.1016/j.jss.2012.01.008
     [Google Scholar]
  34. Shah PJ, Dubey KP, Sahare KK, Agrawal A. Intravenous dexmedetomidine versus propofol for intraoperative moderate sedation during spinal anesthesia: a comparative study. J Anaesthesiol Clin Pharmacol. 2016 Apr-Jun; 32:(2):245–9. https://doi.org/10.4103/0970-9185.168172
     [Google Scholar]
/content/journals/10.5339/qmj.2025.117
Loading
Serious adverse effect of low-dose dexmedetomidine under spinal anesthesia: A case report and literature review
Qatar Medical Journal 2025, 117 (2025); https://doi.org/10.5339/qmj.2025.117
/content/journals/10.5339/qmj.2025.117
/content/journals/10.5339/qmj.2025.117
Loading

Data & Media loading...

  • Article Type: Case Report
Keyword(s): bradycardia, Dexmedetomidine, neuraxial anesthesia, pericardiac arrest and spinal anesthesia

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error